News & Articles

As part of Lab Week, Irena Ivanova shares her perspective on challenges and triumphs in the clinical laboratory

In this LabWeek spotlight, Vilma da Costa Manuel reflects on her journey in clinical science — from her early career to a vision for global health advancement

As part of Lab Week, Eslam Darwish shares how teamwork, innovation, and rigorous quality control drive excellence in laboratory diagnostics and patient care

Dr. Murakami discusses the molecular tools enabling the pursuit of precision medicine

Explore innovations and tools for clinical labs shaping the future of sepsis management, clinical mass spec, anticoagulant diagnostics, and more

Test to be developed for Pseudomonas aeruginosa detection in patients with cystic fibrosis suitable for both detection of new cases and monitoring of chronic infection

Survey finds fear and misconceptions around hepatitis discourage testing, with more than half of respondents assuming they are not at risk

Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds

Explore innovations and tools for clinical labs shaping the future of breast cancer, Alzheimer's, multiple sclerosis, and more

Explore high-sensitivity troponin, antibiotic stewardship, mass spec, and more innovations and tools shaping the future of clinical labs

Partnership seeks to improve patient outcomes and experiences through novel digital and diagnostic solutions

Healthcare thought-leaders share how high-sensitivity troponin immunoassays are changing the face of cardiac care

This innovative technology aims to improve acute care outcomes, particularly for myocardial infarction diagnosis.

Advancing early Alzheimer's diagnosis with scalable, ultra-sensitive technology

Roche Diagnostics leadership answers questions around cobas® mass spectrometry solution launch

Guest editorial by Dr. Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems, Senior Vice President, Roche

Clinical mass spectrometry testing offers sensitivity and specificity, providing clinicians with additional diagnostic insights

Expert roundtable forum discussion to explore the value of high-sensitivity immunoassays

The study was commissioned and funded by the National Institute for Health and Care Research (NIHR), and its leading partners were The University of Manchester, Northern Care Alliance NHS Foundation Trust and Warwick Medical School’s Clinical Trials Unit, who specialize in research in emergency and critical care

T2 Biosystems announces plans to license its proprietary technology to accelerate the broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream

Attend this expert webinar to stay ahead of the latest technological breakthroughs in the monoclonal gammopathy field

Guest editorial by Arindam Ghosh, MBBS, PhD, a physician-scientist by training with extensive experience in neurodegenerative and neuropsychiatric disorders, particularly Alzheimer’s disease and dementia

Guest editorial by Mark Holland, Ph.D. Director, Bioinformatics/Biostatistics for Chemistry and Immunoassay Research and Development, Beckman Coulter